TL;DR
This paper introduces a novel, cost-effective, and highly accurate SNP-based method for non-invasive prenatal paternity testing (NIPPT) using multiplex PCR and targeted capture sequencing. The approach significantly reduces the number of genetic markers needed while maintaining high sensitivity, allowing for paternity determination as early as five weeks of gestation.
What Problem Does This Paper Address?
Prenatal paternity testing is crucial in various forensic and legal contexts, particularly in cases of sexual assault, alimony disputes, and inheritance claims. Traditional methods like amniocentesis or chorionic villus sampling are invasive and carry risks for both mother and fetus, typically performed after 12 weeks of pregnancy. The advent of cell-free fetal DNA (cfDNA) in maternal blood offered a non-invasive alternative, but existing cfDNA-based methods, often relying on a large number of single nucleotide polymorphisms (SNPs), can be complex and expensive. This paper aims to address these limitations by developing a more streamlined, cost-efficient, and sensitive NIPPT method.
Methods
The researchers developed a novel NIPPT approach by combining multiplex PCR targeted capture sequencing with a carefully selected panel of 627 single nucleotide polymorphisms (SNPs).
- SNP Selection: SNPs were chosen from public databases and literature based on specific criteria, including intronic regions, minor allele frequency (MAF) ≥ 0.3, and exclusion of SNPs linked to diseases or functional genomic elements. This rigorous selection process aimed to identify informative and reliable markers.
- Multiplex PCR and Targeted Capture Sequencing: A custom-designed panel was used for library preparation, involving two rounds of multiplex PCR and bead purification. This technique allows for the simultaneous amplification and sequencing of multiple target regions (SNPs) from the cfDNA in maternal plasma.
- Data Analysis: The core of the analysis involved identifying non-maternal allele sequencing reads (NGASRs) in maternal plasma cfDNA. When a mother is homozygous for a particular SNP and the cfDNA shows a heterozygous genotype, the non-maternal allele is inferred to be from the father. A threshold of 2% for the allele fraction was established to distinguish true paternal alleles from sequencing noise.
- Paternity Index (PI) and Combined Paternity Index (CPI): Paternity was determined by calculating the PI for individual SNPs and then combining them to form the CPI. A high CPI value strongly supports paternity, while a low or negative CPI conclusively excludes it.
- Validation: The NIPPT results were validated using traditional PCR-capillary electrophoresis (PCR-CE) based STR genotyping on postpartum child samples. Additionally, Y-SNP detection was used to determine fetal sex, further enhancing the system's utility.
Datasets
- Participant Samples: 15 peripheral blood samples from pregnant women and their suspected fathers were collected.
- Control Samples: Peripheral blood samples from 100 unrelated individuals (70 males, 30 females) were used for population genetic data and to establish a baseline for NGASRs. Six additional control samples (3 males, 2 females with pregnancy experience, 1 female without) were used for comparison.
- Simulated Mixtures: Artificially constructed mixtures with varying proportions of minor components (0.5% to 50%) were used to assess the sensitivity of the method.
Key Insights and Ideas
- Reduced SNP Burden: The study successfully demonstrated that a panel of 627 SNPs, when strategically selected and analyzed using targeted capture sequencing, can achieve high accuracy, significantly reducing the number of SNPs compared to previous methods (e.g., 5,457 SNPs in Chang et al., 2019). This directly translates to lower costs and simplified data processing.
- Early Detection Capability: The method proved effective in determining paternity as early as five weeks of gestation, a significant advancement over invasive methods and earlier cfDNA-based approaches that might require later gestational ages.
- High Sensitivity at Low Fetal Fractions: The research established a detection threshold of 2% fetal fraction (FF) for reliable paternity determination, with 98 effective SNPs detected at this level yielding a substantial CPI. This highlights the method's ability to work with limited amounts of fetal DNA.
- Y-SNP for Sex Determination: The integration of Y-SNP detection in maternal plasma provided a reliable and non-invasive way to determine fetal sex, which is crucial for certain paternity testing scenarios and for understanding maternal plasma DNA composition.
Key Results
- Accurate Paternity Determination: All 15 alleged paternity cases were accurately determined. Biological fathers were confirmed with extremely high Combined Paternity Index (CPI) values, ranging from 1.05 × 10¹⁴ to 2.03 × 10³⁴.
- Effective Exclusion: Unrelated males tested as alleged fathers consistently yielded very low CPI values (log₁₀ CPI < -27.98), allowing for straightforward exclusion.
- High SNP Efficacy: The system identified an average of 58-152 effective SNPs per cfDNA sample.
- Low Error Rate: The NIPPT method demonstrated a low error rate of 0.18% when comparing effective SNPs to fetal gDNA sequencing results.
- Sensitivity Threshold: The method reliably detected paternity with fetal fractions as low as 2%, although performance diminished below this threshold.
Limitations and Future Work
- Gestational Age and FF Influence: While the study achieved paternity determination as early as five weeks, detection failures can still occur due to low fetal fraction (FF), which is influenced by gestational age and other factors. The paper suggests that in forensic practice, extending the gestational age, using more informative SNPs, or employing cffDNA enrichment techniques might be necessary.
- Sample Size and Generalizability: The study involved a limited number of pregnant women, and the MAF of selected SNPs was validated only in a cohort of 100 unrelated Chinese individuals. Future research needs to include more samples from early pregnancies with lower FF and verify the applicability of the method to other ethnic groups.
- Maternal Factors: The impact of maternal BMI and health status on FF could not be assessed due to incomplete sample information.
- Related Males: The study did not analyze the impact of closely related males (e.g., brothers of the suspected father) on paternity testing accuracy. Future work will include these relatives as research samples to refine the method.
- Further Optimization: The authors suggest that future research should focus on gathering more detailed information on factors affecting testing efficiency across different gestational stages and developing more effective analysis methods, potentially incorporating machine learning for auxiliary analysis.
Summary updated